Edap Tms (NASDAQ:EDAP) Price Target Raised to $14.00

Edap Tms (NASDAQ:EDAPGet Rating) had its price objective raised by stock analysts at Lake Street Capital from $12.00 to $14.00 in a research note issued to investors on Friday, The Fly reports. Lake Street Capital’s price objective would suggest a potential upside of 40.70% from the company’s previous close.

Several other equities analysts have also recently weighed in on EDAP. StockNews.com initiated coverage on shares of Edap Tms in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. HC Wainwright lifted their price objective on shares of Edap Tms from $11.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday. Piper Sandler lifted their price objective on shares of Edap Tms from $11.00 to $12.00 in a research report on Thursday. Finally, Jefferies Financial Group initiated coverage on shares of Edap Tms in a research report on Tuesday, November 1st. They set a “buy” rating and a $11.00 price objective for the company.

Edap Tms Price Performance

NASDAQ:EDAP opened at $9.95 on Friday. Edap Tms has a 1-year low of $5.13 and a 1-year high of $10.60. The company has a current ratio of 4.37, a quick ratio of 3.18 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $8.86 and a 200 day simple moving average of $7.73. The stock has a market capitalization of $359.69 million, a PE ratio of 90.46 and a beta of 1.22.

Edap Tms (NASDAQ:EDAPGet Rating) last released its earnings results on Wednesday, August 24th. The medical equipment provider reported $0.06 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.09. Edap Tms had a net margin of 6.76% and a return on equity of 6.42%. The business had revenue of $14.97 million during the quarter, compared to analysts’ expectations of $14.17 million. On average, research analysts expect that Edap Tms will post 0.02 EPS for the current fiscal year.

Institutional Investors Weigh In On Edap Tms

A number of institutional investors have recently modified their holdings of EDAP. Camarda Financial Advisors LLC bought a new stake in shares of Edap Tms in the first quarter valued at about $209,000. JPMorgan Chase & Co. bought a new stake in shares of Edap Tms in the first quarter valued at about $60,000. HighTower Advisors LLC bought a new stake in shares of Edap Tms in the first quarter valued at about $185,000. Rock Springs Capital Management LP boosted its position in shares of Edap Tms by 7.8% in the first quarter. Rock Springs Capital Management LP now owns 820,000 shares of the medical equipment provider’s stock valued at $5,945,000 after acquiring an additional 59,100 shares during the period. Finally, Commonwealth Equity Services LLC boosted its position in shares of Edap Tms by 8.3% in the second quarter. Commonwealth Equity Services LLC now owns 52,225 shares of the medical equipment provider’s stock valued at $355,000 after acquiring an additional 4,000 shares during the period. Institutional investors own 28.53% of the company’s stock.

About Edap Tms

(Get Rating)

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST).

Featured Articles

The Fly logo

Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.